Abstract
Ocular toxicity caused due to pesticide-induced oxidative stress is a topic of great interest in toxicological research in the recent past. The human eye is directly exposed to various toxins especially pesticides. Exposure to pesticides through various routes could lead to severe ocular disorders due to oxidative stress. Antioxidant biomolecules have a great potential to combat the effects of pesticides in ocular structures. Most of these antioxidant biomolecules lack bioavailability in ocular structures; hence developing a novel nanoparticle-based antioxidant formulation could solve this issue and can offer maximum therapeutic potential for antioxidant biomolecules in prevention/control of ocular toxicity induced by pesticide. This review gives a cumulated information on various reported studies on pesticide-induced oxidative stress and how it may cause ocular toxicity. Further in this review, we have discussed how nanotechnology product-based delivery of antioxidant biomolecules could reflect on their therapeutic potential in prevention or control of pesticide-induced oxidative stress and its further effect on ocular health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dich J, Zahm SH, Hanberg A, Adami HO. Pesticides and cancer. Cancer Causes Control. 1997;8:420–43.
Voccia I, Blakley B, Brousseau P, Fournier M. Immunotoxicity of pesticides: a review. Toxicol Ind Health. 1999;15:119–32.
Cooper J, Dobson H. The benefits of pesticides to mankind and the environment. Crop Prot. 2007;26:1337–48.
Charles MB. Impacts of genetically engineered crops on pesticide use in the U.S. -- the first sixteen years. Environ Sci Eur. 2012;24:1–13.
Jeyaratnam J. Acute pesticide poisoning: a major global health problem. World Health Stat Q. 1990;43:139–44.
Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med. 2003;35:1491–9.
Christos AD, Ilias GE. Pesticide exposure, safety issues, and risk assessment indicators. Int J Environ Res Public Health. 2011;8:1402–19.
Gilden RC, Huffling K, Sattler B. Pesticides and health risks. J Obstet Gynecol Neonatal Nurs. 2010;39:103–10.
Fareeda M, Chandrasekharan NK, Manoj KP, Vipin B, Mohammed K, Anup KS. Visual disturbances with cholinesterase depletion due to exposure of agricultural pesticides among farm workers. Toxicol Environ Chem. 2012;94:1601–9.
Sharma Y, Bashir S, Irshad M, Gupta SD, Dogra TD. Effects of acute dimethoate administration on antioxidant status of liver and brain of experimental rats. Toxicology. 2005;206:49–57.
White RE. The involvement of free radicals in the mechanisms of monooxygenases. Pharmacol Ther. 1991;49:21–42.
Hubble JP, Cao T, Hassanein RES, Neuberger JS, Roller WC. Risk factors for Parkinson's disease. Neurology. 1993;43:1693.
Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353–63.
Evans JR. Antioxidant vitamin and mineral supplements for age-related macular degeneration. Cochrane Database Syst Rev. 2002;2:CD000254.
Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis. 1999;5:32.
Coats DK. Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention. Trans Am Ophthalmol Soc. 2005;103:281–312.
Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540–53.
Arden GB, Sivaprasad S. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev. 2011;7:291–304.
Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 2007;48:3805–11.
Zhu Y, Zhang XL, Zhu BF, Ding YN. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats. Mol Biol Rep. 2012;39:3727–35.
Moreau KL, King JA. Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends Mol Med. 2012;18:273–82.
Pavan S, Shashi NJ, Jagat RK, Subhash CY. Natural antioxidant biomolecules promises future nanomedicine based therapy for cataract. Colloids Surf B Biointerfaces. 2013;112:554–62.
Kyselova Z, Garcia SJ, Gajdosikova A, Gajdosik A, Stefek M. Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats. Physiol Res. 2005;54:49–56.
Garner MH, Spector A. Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. PNAS. 1980;77:1274–7.
Donald JE. Pesticide use in developing countries. Toxicology. 2001;160:27–33.
Rodrigo F, Li S, Rodriguez-Rocha H, Michaela B, Mihalis IP. Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson’s disease. Chem Biol Interact. 2010;188:289–300.
Bonneh-Barkay D, Langston WJ, Di Monte DA. Toxicity of redox cycling pesticides in primary mesencephalic cultures. Antioxid Redox Signal. 2005;7:649–53.
Antonio FH, Marina L, Fernando G, RodrÃguez-Barrancob M, Antonio P, López-Guarnidoa O. Evaluation of pesticide-induced oxidative stress from a gene–environment interaction perspective. Toxicology. 2013;307:95–102.
Lukaszewicz-Hussain A. Role of oxidative stress in organophosphate insecticide toxicity – short review. Pestic Biochem Physiol. 2010;98:145–50.
Gennaro G, Zhara A, Marina G, Annabella V, Terrance JK, Lucio GC. Organophosphorus insecticides chlorpyrifos and diazinon and oxidative stress in neuronal cells in a genetic model of glutathione deficiency. Toxicol Appl Pharmacol. 2007;219:181–9.
Gultekin F, Ozturk M, Akdogan M. The effect of organophosphate insecticide chlorpyrifos-ethyl on lipid peroxidation and antioxidant enzymes (in vitro). Arch Toxicol. 2000;74:533–8.
Akhgari M, Abdollahi M, Kebryaeezadeh A, Hosseini R, Sabzevari O. Biochemical evidence for free radical-induced lipid peroxidation as a mechanism for subchronic toxicity of malathion in blood and liver of rats. Hum Exp Toxicol. 2003;22:205–11.
Ismail I, Ismail C. Acute effects of methyl parathion and diazinon as inducers for oxidative stress on certain biomarkers in various tissues of rainbowtrout (Oncorhynchus mykiss). Pestic Biochem Physiol. 2008;92:38–42.
Pathak R, Suke SG, Ahmed T, Ahmed RS, Tripathi AK, Guleria K, Sharma CS, Makhijani SD, Banerjee BD. Organochlorine pesticide residue levels and oxidative stress in preterm delivery cases. Hum Exp Toxicol. 2010;29:351–8.
Pal R, Ahmed T, Kumar V, Suke SG, Ray A, Banerjee BD. Protective effects of different antioxidants against endosulfan-induced oxidative stress and immunotoxicity in albino rats. Indian J Exp Biol. 2009;47:723–9.
Koner BC, Banerjee BD, Ray A. Organochlorine pesticide-induced oxidative stress and immune suppression in rats. Indian J Exp Biol. 1998;36:395–8.
Atamaniuk TM, Kubrak OI, Husak VV, Storey KB, Lushchak VI. The mancozeb-containing carbamate fungicide tattoo induces mild oxidative stress in goldfish brain, liver, and kidney. Environ Toxicol. 2014;29(11):1227–35.
Rajeswary S, Kumaran B, Ilangovan R, Yuvaraj S, Sridhar M, Venkataraman P, Srinivasan N, Aruldhas MM. Modulation of antioxidant defense system by the environmental fungicide carbendazim in Leydig cells of rats. Reprod Toxicol. 2007;24:371–80.
Kesavachandran C, Pathak MK, Fareed M, Bihari V, Mathur N, Srivastava AK. Health risks of employees working in pesticide retail shops: an exploratory study. Indian J Occup Environ Med. 2009;13:121–6.
Rahman T, Ismail H, Towhidul Islam MM, Hossain US. Oxidative stress and human health. Adv Biosci Biotechnol. 2012;3:997–1019.
Williams DL. Oxidative stress and the eye. Vet Clin North Am Small Anim Pract. 2008;38:179–92.
Kirrane EF, Hoppin JA, Kamel F, Umbach DM, Boyes WK, Deroos AJ, Alavanja M, Sandler DP. Retinal degeneration and other eye disorders in wives of farmer pesticide applicators enrolled in the agricultural health study. Am J Epidemiol. 2005;161:1020–9.
Kamel F, Boyes WK, Gladen BC, Rowland AS, Alavanja MC, Blair A, Sandler DP. Retinal degeneration in licensed pesticide applicators. Am J Ind Med. 2000;37:618–28.
Ravneet, Johal MS, Sharma ML. Three-dimensional study on the effect of organophosphate pesticide ‘monocrotophos’ on lens of fish and its recover. Vet Ophthalmol. 2009;12:152–7.
Uppal RK, Johal MS, Sharma ML. Toxicological effects and recovery of the corneal epithelium in Cyprinus carpio communis Linn. exposed to monocrotophos: an scanning electron microscope study. Vet Ophthalmol. 2015 May;18(3):214–20.
Fu Y, Ziren W, Bao J, Yongqiang W, Jing W, Decheng B. Apoptotic effect of organophosphorus insecticide chlorpyrifos on mouse retina in vivo via oxidative stress and protection of combination of vitamins C and E. Exp Toxicol Pathol. 2008;59:415–23.
Jasna JM, Anandbabu K, Bharathi SR, Angayarkanni N. Paraoxonase enzyme protects retinal pigment epithelium from chlorpyrifos insult. PLoS One. 2014;9:1–10.
Hiroko I, Mikio M, Shigekazu U, Satoshi I. Retinal degeneration in rats exposed to an organophosphate pesticide (fenthion). Environ Res. 1983;30:453–65.
Khalid R. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 2007;2:219–36.
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.
Swaran JSF. Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxidative Med Cell Longev. 2009;2:191–206.
Bayani U, Ajay VS, Paolo Z, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65–74.
Banerjee BD, Seth V, Ahmed RS. Pesticide-induced oxidative stress: perspectives and trends. Rev Environ Health. 2001;16:1–40.
Fatma GU, Filiz D, Suna K, Hatice B, Yusuf K. Protective effect of catechin and quercetin on chlorpyrifos-induced lung toxicity in male rats. Food Chem Toxicol. 2010;48:1714–20.
Radhey SV, Anugya M, Nalini S. Comparative studies on chlorpyrifos and methyl parathion induced oxidative stress in different parts of rat brain: attenuation by antioxidant vitamins. Pestic Biochem Physiol. 2009;95:152–8.
Shittua M, Ayoa JO, Ambali SF, Fatihu MY, Onyeanusi BI, Kawua MU. Chronic chlorpyrifos-induced oxidative changes in the testes and pituitary gland of Wistar rats: ameliorative effects of vitamin C. Pestic Biochem Physiol. 2012;102:79–85.
Nadia SA, Aneesa SM, Mosaad AA. Chlorpyrifos-induced oxidative stress and histological changes in retinas and kidney in rats: protective role of ascorbic acid and alpha tocopherol. Pestic Biochem Physiol. 2010;98:33–8.
Avnesh K, Sudesh KY, Subhash CY. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75:1–18.
Arto U. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131–5.
Ripal G, Hari KA, Ashwin P, Ashim KM. Ocular drug delivery. AAPS J. 2010;12:348–60.
Ramesh CN, Kant S, Singh PN, Maiti P, Pandit JK. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release. 2009;136:2–13.
Pahuja P, Arora S, Pawar P. Ocular drug delivery system: a reference to natural polymers. Expert Opin Drug Deliv. 2012;9:837–61.
Sheetu W, Rishi P, Shivani RP, Vyas SP. Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 2009;15:2724–50.
Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13:144–51.
Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials. 2002;23:3247–55.
Bucolo C, Maltese A, Puglisi G, Pignatello R. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension. Ophthalmic Res. 2002;34:319–23.
Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm. 2006;315:12–7.
Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, BenEzra D, Behar-Cohen FF. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci. 2003;44:3562–9.
Sakai T, Kohno H, Ishihara T, Higaki M, Saito S, Matsushima M, Mizushima Y, Kitahara K. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res. 2006;82:657–63.
Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6:324–33.
Gadad AP, Sharat Chandra P, Dandagi PM, Mastiholimath VS. Moxifloxacin loaded polymeric nanoparticles for sustained ocular drug delivery. Int J Phar Sci Nanotechnol. 2012;5:1727–34.
Başaran E, Yazan Y. Ocular application of chitosan. Expert Opin Drug Deliv. 2012;9:701–12.
Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. Chitosan and its role in ocular therapeutics. Mini Rev Med Chem. 2009;9:1639–47.
Jane LG, Clive GW. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv Drug Deliv Rev. 1993;11:349–83.
de Campos AM, Diebold Y, Carvalho EL, Sanchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res. 2004;21:803–10.
Diebold Y, Jarrin M, Saez V, Carvalho EL, Orea M, Calonge M, Seijo B, Alonso MJ. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials. 2007;28:1553–64.
De Campos AM, Sánchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001;224:159–68.
Alia AB, Hanan ME, Riad KE, Hala E, Mohamed E. Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res. 2008;31:1040–9.
Ujwala S, Hadi AM, Kavita S. Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma. J Drug Deliv. 2013;2013:562727.
Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterisation. Eur J Pharm Biopharm. 2008;68:513–25.
de la Fuente M, Seijo B, Alonso MJ. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci. 2008;49:2016–24.
Acknowledgment
Authors are thankful to the National Health and Medical Research Council (NHMRC; APP1050286) and Australia-India Strategic Research Fund (AISRF). The research fellowship to Pavan Sunkireddy from Deakin University is highly acknowledged.
Declaration of Interest
The author reports no declarations of interest. This work was supported by grants from Australia-India Strategic Research Fund (AISRF) and Deakin University.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Sunkireddy, P., Sriramoju, B., Roy, K., Kanwar, R.K., Kanwar, J.R. (2018). Oxidative Stress in Ocular Disorders: Exploring the Link to Pesticide Exposure and Potential for Using Nanotechnology for Antioxidant Delivery. In: Patel, J., Sutariya, V., Kanwar, J., Pathak, Y. (eds) Drug Delivery for the Retina and Posterior Segment Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-95807-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-95807-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95806-4
Online ISBN: 978-3-319-95807-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)